Vaccine potential of a murine gammaherpesvirus-68 mutant deficient for ORF73

References

1. Adler H., Messerle M., Wagner M., Koszinowski U. H. 2000; Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74:6964–6974
   [Google Scholar]
2. Ballestas M. E., Chatis P. A., Kaye K. M. 1999; Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641–644
   [Google Scholar]
3. Collins C. M., Medveczky M. M., Lund T., Medveczky P. G. 2002; The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome. J Gen Virol 83:2269–2278
   [Google Scholar]
4. Efstathiou S., Ho Y. M., Minson A. C. 1990; Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol 71:1355–1364
   [Google Scholar]
5. Flano E., Kim I. J., Moore J., Woodland D. L., Blackman M. A. 2003; Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol 170:3828–3834
   [Google Scholar]
6. Fowler P., Marques S., Simas J. P., Efstathiou S. 2003; ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J Gen Virol 84:3405–3416
   [Google Scholar]
7. Kim I. J., Flano E., Woodland D. L., Blackman M. A. 2002; Antibody-mediated control of persistent gamma-herpesvirus infection. J Immunol 168:3958–3964
   [Google Scholar]
8. Liu L., Usherwood E. J., Blackman M. A., Woodland D. L. 1999; T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J Virol 73:9849–9857
   [Google Scholar]
9. Marques S., Efstathiou S., Smith K. G., Haury M., Simas J. P. 2003; Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol 77:7308–7318
   [Google Scholar]
10. Moorman N. J., Willer D. O., Speck S. H. 2003; The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol 77:10295–10303
    [Google Scholar]
11. Sangster M. Y., Topham D. J., D'Costa S., Cardin R. D., Marion T. N., Myers L. K., Doherty P. C. 2000; Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 164:1820–1828
    [Google Scholar]
12. Schäfer A., Lengenfelder D., Grillhösl C., Wieser C., Fleckenstein B., Ensser A. 2003; The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication. J Virol 77:5911–5925
    [Google Scholar]
13. Stevenson P. G., Doherty P. C. 1998; Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol 72:943–949
    [Google Scholar]
14. Stevenson P. G., Belz G. T., Castrucci M. R., Altman J. D., Doherty P. C. 1999a; A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A 96:9281–9286
    [Google Scholar]
15. Stevenson P. G., Cardin R. D., Christensen J. P., Doherty P. C. 1999b; Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol 80:477–483
    [Google Scholar]
16. Stewart J. P., Janjua N. J., Pepper S. D., Bennion G., Mackett M., Allen T., Nash A. A., Arrand J. R. 1996; Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol 70:3528–3535
    [Google Scholar]
17. Stewart J. P., Usherwood E. J., Ross A., Dyson H., Nash T. 1998; Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 187:1941–1951
    [Google Scholar]
18. Sunil-Chandra N. P., Efstathiou S., Nash A. A. 1992; Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo . J Gen Virol 73:3275–3279
    [Google Scholar]
19. Tibbetts S. A., McClellan J. S., Gangappa S., Speck S. H., Virgin H. W. 2003; Effective vaccination against long-term gammaherpesvirus latency. J Virol 77:2522–2529
    [Google Scholar]
20. Usherwood E. J., Roy D. J., Ward K., Surman S. L., Dutia B. M., Blackman M. A., Stewart J. P., Woodland D. L. 2000; Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med 192:943–952
    [Google Scholar]
21. Usherwood E. J., Ward K. A., Blackman M. A., Stewart J. P., Woodland D. L. 2001; Latent antigen vaccination in a model gammaherpesvirus infection. J Virol 75:8283–8288
    [Google Scholar]
22. Virgin H. W., 4th., Latreille P., Wamsley P., Hallsworth K., Weck K. E., Dal Canto A. J., Speck S. H. 1997; Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71:5894–5904
    [Google Scholar]